15% OFF Retatrutide + Cagrilintide – 10mg/vial (Research Use Only)
An investigational triple agonist (GIP/GLP-1/glucagon) paired with an investigational amylin analogue. Neither compound is approved by FDA or any other regulator. Supplied strictly for laboratory research and identification purposes. Not for human or veterinary use.
Availability: In stock
3–4 vials — 5% off · 5–9 vials — 10% off · 10+ vials — 15% off
Applied automatically in the cart. Combines with a discount code up to 20% off in total, and stacks on top of the subscription discount.
Research Disclaimer: All products currently listed on this site are for research purposes only.
Overview
Retatrutide + Cagrilintide is an advanced dual-peptide combination under active clinical investigation for synergistic metabolic effects. This formulation pairs 5mg Retatrutide (a GLP-1/GIP/glucagon triple agonist) with 5mg Cagrilintide (a long-acting amylin analog) in a single 10mg lyophilized vial.
Components
Retatrutide (5mg) — A novel triple agonist that simultaneously activates GLP-1, GIP, and glucagon receptors. Sponsor-reported clinical trial results for retatrutide are summarised, with sources, in the Research Library rather than on product pages.
Cagrilintide (5mg) — A long-acting amylin analog acting on hypothalamic and brainstem amylin receptors. Amylin analogs are studied for their signalling activity at amylin receptors; published trial data is summarised in the Research Library rather than on product pages.
Product Specifications
Concentration: 10mg/vial (5mg + 5mg) | Format: Lyophilized powder | Purity: ≥98%
For research use only. Not intended for human consumption.
Not sure which compounds fit your research? Browse the Research Hub →
Related Research (Educational)
- Body Recomposition with GLP-1 Peptides: What the Research Shows
- Muscle Preservation During Caloric Restriction: Research Compound Insights
- Visceral Fat and Metabolic Health: What Researchers Are Studying
- GLP-1 Compound Comparison: Retatrutide vs. Tirzepatide vs. Semaglutide
Research Library
- Processing: Orders ship within 1–2 business days
- Domestic delivery: 3–5 business days via USPS Priority / UPS Ground
- Free shipping on orders over $100
- Temperature handling: Cold-chain packaging available on request for lyophilized peptides
- Tracking: Emailed automatically at time of dispatch
- Store lyophilized (dry) peptides at −4 °F for long-term stability
- Protect from light and moisture at all times
- Do not freeze
- Where the Storage row in the product specification above differs, follow the specification
Frequently Asked Questions
Cagrilintide is a long-acting amylin analogue. Amylin receptor agonists act on brainstem satiety centres — the area postrema and nucleus tractus solitarius — a different pathway from GLP-1 receptor agonism. Clinical trials involving cagrilintide used pharmaceutical-grade material under medical supervision.
Yes. Cagrilintide has been studied alone and together with semaglutide in clinical trials. Portal to Wellness supplies this product as a single research formulation. Portal to Wellness does not publish protocols, combinations or quantities, and nothing on this page is a recommendation for use.
Pairs Well With
Related research products
Reviews
There are no reviews yet.